GenesisCare to open rapid lung cancer diagnostics centre in Leeds

The provider of cancer services will open a specialist lung cancer centre in Leeds, introducing a seven-day diagnostic pathway bringing together imaging, specialist assessment and treatment planning

GenesisCare has announced that it will open a specialist lung cancer centre in Leeds, introducing a rapid diagnostic service.

The current plan is for the centre to be open to patients in January 2027.

This “rapid” service is designed to reduce the time between referral, diagnosis and treatment planning.

The centre will use a new Lung Cancer Rapid Response Pathway, bringing together specialist consultations, diagnostic investigations, imaging and multidisciplinary team (MDT) reviews within a coordinated service.

GenesisCare aims to establish whether a patient is likely to have lung cancer within seven days, compared with the Government's current 28-day Faster Diagnosis Standard target.

The provider says the pathway is intended to address delays associated with complex investigations, access to diagnostic equipment and the coordination of specialist input. 

An analysis cited by GenesisCare found that up to 40% of patients do not receive a lung cancer diagnosis within the 28-day target.

How will it work?

At the centre of the new service will be a dedicated digital pathway management system, giving clinicians real-time visibility of each patient's progress, outstanding investigations and next steps. 

Patients will also receive a diagnostic passport to help them follow their journey through the service.

The model will include daily virtual MDT reviews involving specialists in respiratory medicine, radiology, surgery, and medical and clinical oncology. 

Rather than relying solely on scheduled weekly meetings, clinicians will be able to review new results as they become available and make decisions when the necessary information is ready.

Dr Kevin Franks, Consultant Clinical Oncologist at GenesisCare, said the pathway had been designed to bring different stages of the diagnostic process together and give clinical teams greater visibility of patient progress.

“Our plan is to confirm whether a patient is likely to have lung cancer or not within seven days, and our gold standard service will ensure patients receive the right treatment from the right specialists in the quickest time frame possible,” said Franks.

Treatment and patient support

Following diagnosis, patients will be able to access treatment through the centre, depending on their individual diagnosis and clinical suitability.

Options will include MRI-guided stereotactic ablative radiotherapy (SABR), delivered using an MR Linac, and cone-beam CT-guided SABR on a standard linear accelerator. 

These techniques will provide treatment options for peripheral, central and ultra-central lung tumours.

The service will also provide rapid referral to thoracic surgeons for patients suitable for surgery.

Alongside clinical treatment, the centre will offer a wellbeing programme incorporating smoking cessation support, nutritional advice, exercise medicine and prehabilitation.

Patients undergoing investigations or treatment will also have access to a dedicated Lung Clinical Nurse Specialist.

GenesisCare is also introducing a GP Advice service, giving primary care clinicians direct access to respiratory and oncology specialists. 

The service is intended to support referral decisions, provide advice on symptoms and facilitate access to diagnostics.

Addressing delays in lung cancer diagnosis

Lung cancer remains the UK's biggest cancer killer, with nearly 40,000 people diagnosed in England each year, according to figures cited by GenesisCare.

Around a third of people diagnosed with the disease in England are identified following an emergency hospital admission, while 68% of those diagnosed through emergency presentation have stage four disease.

The provider also commissioned research into public awareness of lung cancer symptoms and attitudes towards seeking medical advice.

 It found that 70% of respondents were unaware of all the signs and symptoms, while 49% knew that lung cancer can affect people who have never smoked.

The research suggested that misconceptions about smoking and the stigma associated with the disease could contribute to delays in seeking help.

Dr Jon Robson, Consultant Respiratory Physician at GenesisCare, said the service was intended to make the diagnostic process more responsive without compromising clinical decision-making.

He said: “It’s not about taking short cuts, it’s about reducing delays at each stage and acting faster. That is what’s going to make a real difference to patients’ outcomes.”

The Leeds development forms part of GenesisCare's wider expansion of specialist cancer services across the UK. 

The provider is also preparing to open a new cancer centre in Royal Tunbridge Wells, while its Guildford centre is being expanded with an additional systemic anti-cancer therapy unit. 

The company has also invested in advanced imaging and radiotherapy equipment at its Milton Keynes cancer centre.

You may also like